![](/img/cover-not-exists.png)
Metronomic administration of the drug GMX1777, a cellular NAD synthesis inhibitor, results in neuroblastoma regression and vessel maturation without inducing drug resistance
Dieter Fuchs, Alejandro Rodriguez, Sara Eriksson, Rolf Christofferson, Christian Sundberg, Faranak AzarbayjaniVolume:
126
Year:
2010
Language:
english
Pages:
1
DOI:
10.1002/ijc.25206
File:
PDF, 1.20 MB
english, 2010